Company Filing History:
2 out of 932 
2 out of 832,891 Years Active: 2002-2012
Title: Michael N Pollak: Innovator in CNS Malignancy Treatment
Introduction
Michael N Pollak is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of medical research, particularly in the treatment of central nervous system (CNS) malignancies. With a total of 4 patents to his name, Pollak's work has the potential to impact the lives of many patients suffering from these challenging conditions.
Latest Patents
One of Pollak's latest patents involves a bispecific oligonucleotide designed for the treatment of CNS malignancies. This innovative approach targets the genes encoding IGFBP-2 and IGFBP-5. By administering an antisense oligonucleotide that is complementary to these genes, the treatment aims to reduce the effective levels of IGFBP-2 and IGFBP-5 in the cells affected by CNS malignancy. This method represents a promising advancement in the fight against these serious health issues.
Career Highlights
Throughout his career, Pollak has worked with various institutions, including The University of British Columbia. His research and inventions have garnered attention in the scientific community, showcasing his dedication to improving treatment options for patients with CNS malignancies.
Collaborations
Pollak has collaborated with esteemed colleagues such as Meir J Stampfer and Edward Giovannucci. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
Michael N Pollak stands out as an influential inventor in the realm of medical research, particularly in the treatment of CNS malignancies. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.